Carola Haapamäki
@CHaapamaki
Followers
63
Following
783
Media
2
Statuses
35
Colorectal surgeon, PhD
Helsinki, Finland
Joined September 2018
Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial ➡️ https://t.co/WvgTEZvwft The difference in LRR between TNT and CRT mainly occurred in patients treated with
0
77
164
Management and risk factors for colonic volvulus: retrospective national cohort study ➡️ https://t.co/sXf9zkxxTe Surgery should be recommended for colonic volvulus where co-morbidity, patient preference, and functional status allows. Surgically unfit patients have poorer
0
13
16
The results of the ALASCCA RCT, showing lower recurrence rate after adjuvant aspirin in patients with local CRC and PIK3CA mutations in exon 9 or 20, are published. As the PI in Finland I’d like to thank all collaborators at Meilahti and Jorvi Hospitals (Helsinki University
In patients with localized colorectal cancer and PIK3CA hotspot mutations in exon 9 or 20, daily low-dose aspirin resulted in a significantly lower recurrence rate than placebo. ALASCCA phase 3 trial results: https://t.co/c5FAYCmKwI Editorial: An Aspirin a Day for Improved
0
1
3
#GI25 drawing to a close @ASCO Congrats to organizers & presenters 👏 🌟 My top 3 picks for practice-changing trials 👉all in #CRCsm molecularly defined subsets 🎯 🌟 CM8HW in dMMR mCRC @TheLancet 🌟BREAKWATER in BRAFV600E mCRC @NatureMedicine @skopetz 🌟 ALASCCA in
1
8
22
Well done Anna! Proud to have participated in this trial with my team at Helsinki University Hospital, Colorectal Unit
@Annamartling rand dbl-blind ALASCCA trial of adjuvant aspirin 160 mg daily x3 yrs in resected stage I-III #rectal or II-III #colon cancer ➡️ 37% screened had #PI3K alt w/reduced #CRC recurrence (HR 0.42-0.49) vs placebo. 50% got adj chemo for colon cancer #GI25
@OncoAlert
0
0
0
Introducing our new ISS/SIC President, Ari K. Leppäniemi! 🎉 We are thrilled to have his leadership guiding us forward. Read more https://t.co/fCNAknvYOi 🌍💼 #isssic #Leadership #GlobalImpact #SurgeryExcellence
0
3
7
Great interactive discussion during the @escp_tweets #ESCP24 Women’s Breakfast Symposium led by @GabrielleVanRam @marianaberho
2
10
43
presentation of our upcoming PROSPERITY trial at #escp2024 by @LauraKoskenvuo
@villesallinen @Adductor
1
4
6
#DCRJournal visual abstract: Local Regrowth and the Risk of Distant Metastases Among Patients Undergoing Watch-and-Wait for Rectal Cancer: What Is the Best Control Group? Multicenter Retrospective Study: https://t.co/SjMTBdoL7W
@Swexner @me4_so @ACPGBI @drtracyhull @ASCRS_1
2
23
68
Our MOBILE2 trial is finally out in @JAMASurgery Oral antibiotics are beneficial, with no doubt, prior anterior rectal resection! Huge thanks to all our team! @villesallinen @CHaapamaki
Double-blinded MOBILE2-trial found that mechanical bowel preparation and oral antibiotics reduced the rate of overall morbidity, surgical site infections and anastomotic leaks compared to mechanical bowel preparation only prior anterior rectal resection. https://t.co/1mVNqwWmMx
1
16
40
The 2023 @ASCRS_1 Clinical Practice Guidelines for #RectalCancer just dropped in the Jan '24 @DCRjournal issue. So much hard work went into this from all authors. Topics covered in depth: -TNT -Watch-and-wait -TaTME -Mgmt intraperitoneal rectal cancers https://t.co/crhRH1t6Qs
3
98
254
Looking forward to the meeting! @LauraKoskenvuo @LauraRenkonen
10 days until Rectal Cancer Forum 2022 in Stockholm, agenda https://t.co/34R5XTJf8z
@karolinskainst @karolinskaUnsju @Annamartling
@CancerResKI @ProfessorHeald @ansjov @PerJNilsson1 @evaangenete #ColorectalSurgery @eloiespin
0
0
1
Nordic Peritoneal Oncology Group meeting 2022.@CHaapamaki @Adductor Very nice to meet everybody in person after two years with online meetings only
0
2
7
Tänään vetoamme päättäjiin maamme suurimmissa sanomalehdissä. Suomella ei ole varaa leikata tutkimuksesta ja koulutuksesta. Suunnitellut tiedeleikkaukset on peruttava budjettiriihessä. @okmfi @valtioneuvosto @MarinSanna @kurvisentwiit @liandersson #tiede #tutkimus #budjettiriihi
6
114
478
Protocol of our #MOBILE2 trial comparing MOABP (Mechanical and Oral Antibiotic Bowel Preparation) vs. MBP (Mechanical Bowel Preparation) in rectal resections @villesallinen @CHaapamaki @BMJ_Open @LunkkaPipsa
0
4
16
The 🌟Retro-Rectal Tumour🌟. How do you manage them? What factors are associated with malignancy? @ACPGBI @Dukes_Club @escp_tweets Study: Clinical management of 52 consecutive retro‐rectal tumours treated at a tertiary referral centre
0
6
24
Low Anterior Resection Syndrome (LARS) after TaTME (Bottom-Up) vs. Conventional (Top-to-Bottom) Approach: https://t.co/Sm723G240A
#ColorectalResearch
@JISBMD @ConorDelaneyMD @justinmaykel @dubaicolorectal @SamAtallahMD @JohnRTMonsonMD @Swexner @ACPGBI @drtracyhull @ASCRS_1
1
34
55
🚨#ESCP2020 Vilnius Announcement🚨 It is with sadness that today we announce the cancellation of our Annual Meeting in Vilnius. An update from President @WBemelman, General Secretary @GabrielaMoslein & Education Committee Chair @d_hahnd is shared below. https://t.co/dlgbVBdtvY
9
44
47